AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Gli2Met-P Tablet ER

Prescription Icon
Prescription Required

Marketer

Stature Life Sciences

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)

Overview Gli2Met-P Tablet ER

Combiflor ER tablets manage blood glucose levels in adults with type 2 diabetes. Used alongside diet and exercise, this combination medication enhances insulin effectiveness, reducing blood sugar. Dosage and frequency should strictly follow your physician's instructions; take with food to prevent digestive discomfort. A missed dose should be taken promptly unless nearing the next scheduled dose, in which case it should be omitted. Never double the dose; overdose can cause dangerously low blood sugar (hypoglycemia). Concurrent use with other diabetes medications, alcohol consumption, or meal skipping increases hypoglycemia risk; regular blood sugar monitoring is crucial. Common side effects may include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, inform your doctor of any kidney, liver, or heart conditions, and pregnant or breastfeeding individuals must seek medical advice. Kidney function will be assessed before treatment initiation. Limit alcohol consumption to mitigate potential adverse effects.

Uses of Gli2Met-P Tablet ER

Managing type 2 diabetes

Major Benefits of Gli2Met-P Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Gli2Met-P Tablet ER whole; avoid chewing, crushing, or breaking it. Administer this medicine with a meal.

Common Side effects of Gli2Met-P Tablet ER:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Nausea
  • Diarrhea
  • Dizziness
  • Vomiting
  • Anemia (low number of red blood cells)
  • Weakness
  • Sinus infection

How to use Gli2Met-P Tablet ER:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Gli2Met-P Extended-Release Tablets should be administered with a meal.

How Gli2Met-P Tablet ER works:

Gli2Met-P Extended-Release tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. Their varied mechanisms of action synergistically manage blood sugar levels when monotherapy or dual drug regimens prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood glucose. Metformin, a biguanide, decreases hepatic glucose production, slows intestinal glucose absorption, and enhances insulin responsiveness. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Gli2Met-P Tablet ER is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Gli2Met-P tablet might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible hazards prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Gli2Met-P tablets pose a likely risk during lactation. Available human data indicate potential transfer to breast milk with consequent infant harm.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar abnormalities.

KidneyKidneyCAUTION

Exercise caution when prescribing Gli2Met-P Tablet ER to individuals with impaired renal function; dosage modification may be necessary. Consult a physician before administering. Gli2Met-P Tablet ER is contraindicated in patients exhibiting severe kidney disease. Close monitoring of renal function is recommended throughout the treatment period.

LiverLiverCAUTION

Exercise caution when prescribing Gli2Met-P Tablet ER to individuals with hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Gli2Met-P Tablet ER is contraindicated in patients exhibiting severe liver dysfunction.

What if you forget to take Gli2Met-P Tablet ER :

Should you forget a Gli2Met-P Tablet ER dose, administer it immediately. However, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Gli2Met-P Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Gli2Met-P Tablet ER

Consuming alcohol while taking Gli2Met-P Tablet ER is unsafe. Alcohol can cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Consult your doctor before using Gli2Met-P Tablet ER if you have congestive heart failure, kidney or liver problems, or eye swelling. Also inform your doctor if you are pregnant, breastfeeding, or premenopausal, and of all medications, vitamins, and herbal supplements you are taking, including over-the-counter drugs.
Gli2Met-P ER tablets, containing metformin, can lead to vitamin B12 deficiency. Prolonged use impairs the stomach's absorption of vitamin B12.
Gli2Met-P ER Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always keep a quick-acting sugar source, such as candy or chocolate, on hand.
Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Gli2Met-P Tablet ER
81
MRP 99
18% off